Only 25% of patients who were identified self-reported having been diagnosed with prediabetes or type 2 diabetes.
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
Total nitrates consumption increases a person’s risk of developing type 2 diabetes.
Rybelsus is a glucagon-like peptide receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Weight loss pharmacotherapy recommended as adjunct to health behavior and lifestyle treatment in children 12 years and older with obesity.
California Attorney General Rob Bonta is taking 3 major drugmakers and 3 distributors to court, alleging the companies illegally raised prices at the expense of diabetes patients.
Authors say findings could help with culturally competent guidance about menopause.
Investigators sought to evaluate the effect of subcutaneous semaglutide therapy for treatment of obesity in adolescents.
Layered approach involves initially combining lifestyle interventions, self-management, and first-line pharmacotherapy.
December FDA approvals include treatments for weight loss in adolescents, major depressive disorder, lung cancer detection, metastatic non-small cell lung cancer, multiple sclerosis, and lymphoma.
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
A 33 person panel of physicians, registered dietitian nutritionists, and nutritional epidemiologists assessed 24 diets to come up with the final results.
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Hazard of incident diabetes reduced by 44% in adjusted models comparing average daily step count of 10,700 to 6000.
Meta-analysis results show the prevalence of obesity among children with type 2 diabetes.
Extended method uses additional data from 1999 to 2016 NHANES, rather than extrapolation; improves characterization of extremely high BMI in children
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
SGLT2 inhibitors are associated with lowest probability for adverse outcomes followed by GPL1 receptor agonists and metformin
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Researchers examined the association between obesity and risk for surgical procedures, hospitalization, and serious infections in patients with IBD treated with biologics.